These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31239309)

  • 1. How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
    Epelbaum S; Paquet C; Hugon J; Dumurgier J; Wallon D; Hannequin D; Jonveaux T; Besozzi A; Pouponneau S; Hommet C; Blanc F; Berly L; Julian A; Paccalin M; Pasquier F; Bellet J; Boutoleau-Bretonniere C; Charriau T; Rouaud O; Madec O; Mouton A; David R; Bekadar S; Fabre R; Liegey E; Deberdt W; Robert P; Dubois B
    BMJ Open; 2019 Jun; 9(6):e029663. PubMed ID: 31239309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
    Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
    Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    Bousiges O; Bombois S; Schraen S; Wallon D; Quillard MM; Gabelle A; Lehmann S; Paquet C; Amar-Bouaziz E; Magnin E; Miguet-Alfonsi C; Delbeuck X; Lavaux T; Anthony P; Philippi N; Blanc F;
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):467-475. PubMed ID: 29321140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
    Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
    J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?
    Cretin B; Sellal F; Philippi N; Bousiges O; Di Bitonto L; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016 Apr; 52(3):1125-33. PubMed ID: 27104892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
    J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.
    Cognat E; Mouton Liger F; Troussière AC; Wallon D; Dumurgier J; Magnin E; Duron E; Gabelle A; Croisile B; de la Sayette V; Jager A; Blanc F; Bouaziz-Amar E; Miguet-Alfonsi C; Quillard M; Schraen S; Philippi N; Beaufils E; Pasquier F; Hannequin D; Robert P; Hugon J; Paquet C;
    BMJ Open; 2019 May; 9(5):e026380. PubMed ID: 31152032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA).
    Herr M; Ankri J; Diard C; Hiance-Delahaye A
    Drugs Aging; 2021 Jan; 38(1):63-74. PubMed ID: 33410119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    Burnham SC; Raghavan N; Wilson W; Baker D; Ropacki MT; Novak G; Ames D; Ellis K; Martins RN; Maruff P; Masters CL; Romano G; Rowe CC; Savage G; Macaulay SL; Narayan VA; ;
    J Alzheimers Dis; 2015; 46(4):1079-89. PubMed ID: 26402634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.
    Le Duff F; Develay AE; Quetel J; Lafay P; Schück S; Pradier C; Robert P;
    J Alzheimers Dis; 2012; 29(4):891-902. PubMed ID: 22366771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature.
    Xie J; Gabelle A; Dorey A; Garnier-Crussard A; Perret-Liaudet A; Delphin-Combe F; Bathsavanis A; Dauphinot V; Lehmann S; Mercier B; Desestret V; Roullet-Solignac I; Vighetto A; Krolak-Salmon P
    J Alzheimers Dis; 2014; 41(4):1109-16. PubMed ID: 24762946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forecasting the Prevalence of Alzheimer's Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022.
    Gabelle A; Guéry M; Doutriaux A; Bettayeb K
    J Prev Alzheimers Dis; 2023; 10(2):259-266. PubMed ID: 36946453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.